Clinuvel Pharmaceuticals Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	6/30/2022	6/30/2023	6/30/2024	6/30/2026	6/30/2027
Revenue % change YoY	$65.72M N/A	$78.32M 19.17%	$88.17M 12.58%	Avg: $103.01M Low: $103.01M High: $103.01M avg. 16.82%	Avg: $306.42M Low: $306.42M High: $306.42M avg. 197.44%
Net Income % change YoY	$20.87M N/A	$30.60M 46.58%	$35.63M 16.44%	Avg: $37.42M Low: $37.42M High: $37.42M avg. 5.00%	Avg: $125.00M Low: $125.00M High: $125.00M avg. 234.04%
EBITDA % change YoY	$33.84M N/A	$41.69M 23.22%	$56.27M 34.95%	Avg: $51.28M Low: $51.28M High: $51.28M avg. -8.87%	Avg: $152.54M Low: $152.54M High: $152.54M avg. 197.44%
EPS % change YoY	$0.42 N/A	$0.62 47.61%	$0.7 12.90%	Avg: $0.72 Low: $0.72 High: $0.72 avg. 3.16%	Avg: $2.41 Low: $2.41 High: $2.41 avg. 234.04%
Operating Expenses % change YoY	$13.53M N/A	$9.67M -28.48%	$31.29M 223.32%	Avg: $18.65M Low: $18.65M High: $18.65M avg. -40.40%	Avg: $55.48M Low: $55.48M High: $55.48M avg. 197.44%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 119.52% in 2026-2027.

We have gathered data from N/A analysts. Their low estimate is 37.42M, average is 37.42M and high is 37.42M.

Wall Street analysts forecast annual average revenue growth of 107.13% in 2026-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $103.01M, average is $103.01M and high is $103.01M.

Wall Street analysts forecast annual average earnings growth of 118.60% in 2026-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $0.72, average is $0.72 and high is $0.72.